Historical record - last NADAC publication: 1/17/2018

Product Information

DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.0845 per ML under NDC 00054319446. Its NADAC has been published 261 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the Diphenoxylate Hydrochloride and Atropine Sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID

Diphenoxylate Hydrochloride and Atropine Sulfate
$1.0845per ML
High Outlier
DEA Schedule CV

Strength

.025; 2.5 mg/5mL; mg/5mL

NDC

00054319446

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Last Updated

1/17/2018

Approval Type

Generic (ANDA)

FDA Application

ANDA087708

On Market Since

5/3/1982

Pharmacological Classes

Anticholinergic
Antidiarrheal
Cholinergic Antagonists
Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price Statistics

The NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID has been published 261 times since Nov 28, 2013, and over the history we have for it it has risen 742.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0845 per ML
All-time high$1.0845 (Jan 16, 2019)
All-time low$0.1265 (Dec 18, 2013)
Median price$0.2183
Average price$0.3591
Largest weekly change+387.6% (Jan 17, 2018)
Weeks tracked261
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+742.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Diphenoxylate Hydrochloride and Atropine Sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID?

The current National Average Drug Acquisition Cost (NADAC) for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID, manufactured by Hikma Pharmaceuticals USA Inc., is $1.0845 per ML (NDC 00054319446), effective Jan 16, 2019.

How has the price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID changed over time?

Over the history we have for it, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID has risen 742.2%. It has been tracked across 261 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID?

Since Nov 28, 2013, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID has ranged from a low of $0.1265 (Dec 18, 2013) to a high of $1.0845 (Jan 16, 2019), with a median of $0.2183 per ML.

Are there cheaper alternatives to DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID, so no direct lower-cost alternative is listed.

Who manufactures DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID?

DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID (NDC 00054319446) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.